Nutrien (NTR) Financials

$59.76 +0.09 (+0.15%)

Closing price 05/27/2025 03:59 PM Eastern

Extended Trading

$59.80 +0.04 (+0.06%)

As of 05/27/2025 07:30 PM Eastern

Annual Income Statements for Nutrien

This table shows Nutrien's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Net Income / (Loss) Attributable to Common Shareholders	1,797	2,641	7,687	6,358	459	1,232	7,160	327
Consolidated Net Income / (Loss)	700	1,282	7,687	3,179	459	1,232	3,573	327
Net Income / (Loss) Continuing Operations	1,097	1,359	7,687	3,179	459	1,232	3,587	154
Total Pre-Tax Income	1,136	1,952	10,246	4,168	382	1,308	3,494	-29
Total Operating Income	1,856	2,745	10,809	4,781	902	1,862	4,032	209
Total Gross Profit	7,530	8,474	15,424	9,409	5,239	5,502	5,392	694
Total Revenue	25,972	29,056	37,884	27,712	20,908	20,084	18,772	4,547
Operating Revenue	25,972	29,056	37,884	27,712	20,908	20,084	18,772	4,547
Total Cost of Revenue	18,442	20,582	22,460	18,303	15,669	14,582	13,380	3,853
Operating Cost of Revenue	18,442	20,582	22,460	18,303	15,669	14,582	13,380	3,853
Total Operating Expenses	5,277	5,652	4,615	4,628	4,337	3,400	1,360	485
Selling, General & Admin Expense	4,079	4,023	3,979	3,817	3,311	3,013	2,760	214
Other Operating Expenses / (Income)	668	855	1,416	778	202	507	409	271
Impairment Charge	530	774	-780	33	824	-120	-1,809	0.00
Total Other Income / (Expense), net	-720	-793	-563	-613	-520	-554	-538	-238
Other Income / (Expense), net	-720	-793	-563	-613	-520	-554	-538	-238
Income Tax Expense	436	670	2,559	989	-77	316	-93	-183
Net Income / (Loss) Attributable to Noncontrolling Interest	-26	-24	-	-26	0.00	-	-	-
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-674	-1,258	-	-3,153	-	-	-	-
Basic Earnings per Share	$1.36	$2.53	-	$5.53	$0.81	$1.70	$5.72	$0.39
Weighted Average Basic Shares Outstanding	494.20M	496.38M	-	569.66M	569.66M	582.27M	624.90M	840.08M
Diluted Earnings per Share	$1.36	$2.53	-	$5.52	$0.81	$1.70	$5.72	$0.39
Weighted Average Diluted Shares Outstanding	494.37M	496.99M	-	571.29M	569.69M	583.10M	624.90M	840.32M

No quarterly income statements for Nutrien are available.

This table details how cash moves in and out of Nutrien's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Net Change in Cash & Equivalents	2,117	1,786	9,968	-2,184	243	-1,643	3,600	84
Net Cash From Operating Activities	2,806	2,861	10,000	3,886	3,323	3,665	2,052	-1,225
Net Cash From Continuing Operating Activities	2,806	2,861	10,000	3,814	3,323	3,665	5,474	1,081
Net Income / (Loss) Continuing Operations	700	1,282	7,687	3,179	459	992	3,573	327
Consolidated Net Income / (Loss)	700	1,282	7,687	3,179	459	992	3,573	-327
Depreciation Expense	2,339	2,169	2,012	1,951	1,989	1,799	1,592	-
Non-Cash Adjustments To Reconcile Net Income	-311	-532	-154	373	893	224	1,925	-898
Changes in Operating Assets and Liabilities, net	78	-58	455	-1,689	-18	650	-1,616	-
Net Cash From Investing Activities	112	31	0.00	-1,807	-1,204	-2,798	3,887	-652
Net Cash From Continuing Investing Activities	112	31	0.00	-2,964	-1,744	-2,798	1,867	-652
Purchase of Investments	112	31	-	-	-	-198	-	0.00
Net Cash From Financing Activities	-801	-1,106	-32	-3,003	-1,339	-2,479	-3,705	-489
Net Cash From Continuing Financing Activities	-801	-1,106	-32	-3,003	-1,339	-2,479	-3,705	-489
Repayment of Debt	-659	-648	-561	-1,195	-1,690	-794	-960	-159
Issuance of Debt	-142	-458	529	86	1,541	1,481	0.00	-1.00
Cash Interest Paid	740	729	482	491	498	505	507	-

No quarterly cash flow statements for Nutrien are available.

This table presents Nutrien's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Total Assets	51,840	52,749	54,586	49,954	47,192	46,799	45,502	16,998
Total Current Assets	13,792	14,170	16,342	13,846	11,470	10,665	11,662	3,323
Cash & Equivalents	853	941	901	499	1,454	671	2,314	116
Accounts Receivable	5,390	5,398	6,194	5,366	3,626	3,542	3,342	489
Inventories, net	6,148	6,336	7,632	6,328	4,930	4,975	4,917	2,646
Prepaid Expenses	1,401	1,495	1,615	1,653	1,460	1,477	1,089	72
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	19,660	20,335	18,796	0.00
Total Noncurrent Assets	14,746	15,382	16,477	36,108	16,062	15,799	15,044	13,675
Goodwill	12,043	12,114	12,368	12,220	12,198	11,986	11,431	97
Intangible Assets	1,819	2,217	2,297	2,340	2,388	2,428	2,210	69
Other Noncurrent Operating Assets	884	1,051	1,812	20,845	914	564	1,403	13,509
Total Liabilities & Shareholders' Equity	51,840	52,749	54,586	49,954	47,192	46,799	45,502	16,998
Total Liabilities	27,398	27,548	28,723	26,255	24,789	23,930	21,077	8,695
Total Current Liabilities	12,045	12,121	14,280	12,443	8,480	9,129	8,335	1,602
Short-Term Debt	2,571	2,327	2,684	2,105	173	1,478	1,624	730
Accrued Expenses	9,118	9,467	11,291	10,052	-	-	-	836
Other Current Liabilities	356	327	305	286	249	214	8.00	-
Total Noncurrent Liabilities	15,353	15,427	14,443	13,812	16,309	14,801	12,742	7,093
Long-Term Debt	9,045	9,113	8,275	7,521	10,047	8,553	7,755	3,711
Capital Lease Obligations	999	999	899	-	891	859	12	-
Asset Retirement Reserve & Litigation Obligation	1,543	1,489	1,403	1,566	1,597	1,650	1,673	651
Noncurrent Deferred & Payable Income Tax Liabilities	3,539	3,574	3,547	3,165	3,149	3,145	2,907	2,205
Noncurrent Employee Benefit Liabilities	227	252	319	419	454	433	395	440
Total Equity & Noncontrolling Interests	24,442	25,201	25,863	23,699	22,403	22,869	24,425	8,303
Total Preferred & Common Equity	24,407	25,156	25,818	23,699	22,403	22,869	24,425	8,303
Total Common Equity	24,407	25,156	25,818	23,652	22,365	22,869	24,425	8,303
Common Stock	13,816	13,921	14,281	15,457	15,878	16,019	16,971	1,806
Retained Earnings	11,106	11,531	11,928	8,192	6,606	7,101	7,745	6,242
Accumulated Other Comprehensive Income / (Loss)	-515	-296	-391	-146	-119	-251	-291	25
Noncontrolling Interest	35	45	45	-	-	-	-	-

No quarterly balance sheets for Nutrien are available.

This table displays calculated financial ratios and metrics derived from Nutrien's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	-10.61%	-23.30%	36.71%	32.54%	4.10%	6.99%	312.84%	0.00%
EBITDA Growth	-15.68%	-66.38%	100.33%	158.08%	-23.69%	-38.91%	17,637.93%	0.00%
EBIT Growth	-41.80%	-80.95%	145.83%	991.10%	-70.80%	-62.56%	12,148.28%	0.00%
NOPAT Growth	-36.56%	-77.77%	122.39%	236.45%	-23.25%	-65.88%	2,729.34%	0.00%
Net Income Growth	-45.40%	-83.32%	141.81%	592.59%	-62.74%	-65.52%	992.66%	0.00%
EPS Growth	-46.25%	0.00%	0.00%	581.48%	-52.35%	-70.28%	1,366.67%	0.00%
Operating Cash Flow Growth	-1.92%	-71.39%	157.33%	16.94%	-9.33%	78.61%	267.51%	0.00%
Free Cash Flow Firm Growth	-48.01%	-86.68%	733.33%	63.08%	555.42%	97.03%	0.00%	0.00%
Invested Capital Growth	-4.44%	-10.30%	-53.14%	1.98%	-2.38%	5.97%	149.46%	0.00%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	28.99%	29.16%	40.71%	33.95%	25.06%	27.39%	28.72%	15.26%
EBITDA Margin	13.38%	14.18%	32.36%	22.08%	11.34%	15.47%	27.09%	-0.64%
Operating Margin	7.15%	9.45%	28.53%	17.25%	4.31%	9.27%	21.48%	4.60%
EBIT Margin	4.37%	6.72%	27.05%	15.04%	1.83%	6.51%	18.61%	-0.64%
Profit (Net Income) Margin	2.70%	4.41%	20.29%	11.47%	2.20%	6.13%	19.03%	7.19%
Tax Burden Percent	61.62%	65.68%	75.02%	76.27%	120.16%	94.19%	102.26%	-1,127.59%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	38.38%	34.32%	24.98%	23.73%	-20.16%	24.16%	-2.66%	0.00%
Return on Invested Capital (ROIC)	8.66%	12.63%	34.38%	11.46%	3.40%	4.50%	18.76%	1.16%
ROIC Less NNEP Spread (ROIC-NNEP)	12.48%	17.25%	69.78%	6.13%	-3.36%	2.17%	8.83%	5.34%
Return on Net Nonoperating Assets (RNNOA)	-5.84%	-7.61%	-3.36%	2.33%	-1.37%	0.71%	3.07%	2.78%
Return on Equity (ROE)	2.82%	5.02%	31.02%	13.79%	2.03%	5.21%	21.83%	3.94%
Cash Return on Invested Capital (CROIC)	13.21%	23.49%	106.75%	9.50%	5.81%	-1.30%	-66.78%	0.00%
Operating Return on Assets (OROA)	2.17%	3.64%	19.60%	8.58%	0.81%	2.83%	11.18%	-0.17%
Return on Assets (ROA)	1.34%	2.39%	14.71%	6.54%	0.98%	2.67%	11.43%	1.92%
Return on Common Equity (ROCE)	2.82%	5.01%	30.96%	13.77%	2.03%	5.21%	21.83%	3.94%
Return on Equity Simple (ROE_SIMPLE)	2.87%	5.10%	29.77%	13.41%	2.05%	5.39%	14.63%	3.94%
Net Operating Profit after Tax (NOPAT)	1,144	1,803	8,109	3,647	1,084	1,412	4,139	146
NOPAT Margin	4.40%	6.20%	21.41%	13.16%	5.18%	7.03%	22.05%	3.22%
Net Nonoperating Expense Percent (NNEP)	-3.82%	-4.63%	-35.41%	5.34%	6.76%	2.34%	9.93%	-4.18%
Return On Investment Capital (ROIC_SIMPLE)	3.09%	4.79%	-	-	-	-	-	-
Cost of Revenue to Revenue	71.01%	70.84%	59.29%	66.05%	74.94%	72.61%	71.28%	84.74%
SG&A Expenses to Revenue	15.71%	13.85%	10.50%	13.77%	15.84%	15.00%	14.70%	4.71%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	20.32%	19.45%	12.18%	16.70%	20.74%	16.93%	7.24%	10.67%
Earnings before Interest and Taxes (EBIT)	1,136	1,952	10,246	4,168	382	1,308	3,494	-29
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,475	4,121	12,258	6,119	2,371	3,107	5,086	-29
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.91	1.05	0.00	1.72	1.12	1.06	1.00	0.00
Price to Tangible Book Value (P/TBV)	2.10	2.45	0.00	4.47	3.22	2.87	2.26	0.00
Price to Revenue (P/Rev)	0.85	0.91	0.00	1.46	1.20	1.21	1.30	0.00
Price to Earnings (P/E)	12.31	10.04	0.00	6.39	54.55	19.70	3.41	0.00
Dividend Yield	6.03%	3.97%	2.72%	3.10%	4.10%	4.23%	4.18%	0.00%
Earnings Yield	8.12%	9.96%	0.00%	15.66%	1.83%	5.08%	29.36%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.63	2.82	0.00	1.53	1.08	1.04	1.00	0.00
Enterprise Value to Revenue (EV/Rev)	1.31	1.31	0.00	1.77	1.63	1.68	1.68	0.00
Enterprise Value to EBITDA (EV/EBITDA)	9.76	9.24	0.00	8.01	14.40	10.84	6.19	0.00
Enterprise Value to EBIT (EV/EBIT)	29.86	19.50	0.00	11.76	89.36	25.74	9.01	0.00
Enterprise Value to NOPAT (EV/NOPAT)	29.66	21.11	0.00	13.44	31.50	23.84	7.60	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	12.09	13.30	0.00	12.61	10.27	9.19	15.33	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	19.45	11.35	0.00	16.22	18.42	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.52	0.49	0.46	0.41	0.50	0.48	0.38	0.53
Long-Term Debt to Equity	0.41	0.40	0.35	0.32	0.49	0.41	0.32	0.45
Financial Leverage	-0.47	-0.44	-0.05	0.38	0.41	0.33	0.35	0.52
Leverage Ratio	2.11	2.10	2.11	2.11	2.08	1.95	1.91	2.05
Compound Leverage Factor	2.11	2.10	2.11	2.11	2.08	1.95	1.91	2.05
Debt to Total Capital	34.04%	33.05%	31.44%	28.89%	33.15%	32.26%	27.77%	34.85%
Short-Term Debt to Total Capital	6.94%	6.18%	7.12%	6.32%	0.52%	4.38%	4.80%	5.73%
Long-Term Debt to Total Capital	27.10%	26.87%	24.32%	22.57%	32.64%	27.88%	22.97%	29.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.09%	0.12%	0.12%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	65.86%	66.83%	68.44%	70.97%	66.73%	67.74%	72.23%	65.15%
Debt to EBITDA	3.63	3.02	0.97	1.57	4.69	3.51	1.85	-153.14
Net Debt to EBITDA	3.38	2.79	0.89	1.38	3.84	3.02	1.39	-149.14
Long-Term Debt to EBITDA	2.89	2.45	0.75	1.23	4.61	3.03	1.53	-127.97
Debt to NOPAT	11.03	6.90	1.46	2.64	10.25	7.71	2.27	30.36
Net Debt to NOPAT	10.28	6.38	1.35	2.31	8.39	6.66	1.71	29.56
Long-Term Debt to NOPAT	8.78	5.61	1.13	2.06	10.09	6.67	1.88	25.37
Altman Z-Score	1.40	1.60	0.00	2.02	1.35	1.38	1.69	0.00
Noncontrolling Interest Sharing Ratio	0.16%	0.18%	0.19%	0.18%	0.08%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	1.15	1.17	1.14	1.11	1.35	1.17	1.40	2.07
Quick Ratio	0.52	0.52	0.50	0.47	0.60	0.46	0.68	0.38
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,744	3,354	25,179	3,022	1,853	-407	-14,735	0.00
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	0.00%	193.81%	0.00%	-188.17%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.50	0.54	0.72	0.57	0.44	0.44	0.60	0.27
Accounts Receivable Turnover	4.82	5.01	6.55	6.16	5.83	5.84	9.80	9.30
Inventory Turnover	2.95	2.95	3.22	3.25	3.16	2.95	3.54	1.46
Fixed Asset Turnover	0.00	0.00	0.00	0.00	1.05	1.03	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	2.02	2.06	0.00	0.00
Days Sales Outstanding (DSO)	75.81	72.81	55.69	59.22	62.57	62.55	37.24	39.25
Days Inventory Outstanding (DIO)	123.54	123.85	113.43	112.25	115.37	123.80	103.16	250.66
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	180.47	176.97	0.00	0.00
Cash Conversion Cycle (CCC)	199.35	196.66	169.12	171.47	-2.54	9.39	140.40	289.91
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	12,902	13,502	15,053	32,123	31,498	32,267	31,502	12,628
Invested Capital Turnover	1.97	2.04	1.61	0.87	0.66	0.64	0.85	0.36
Increase / (Decrease) in Invested Capital	-600	-1,551	-17,070	625	-769	1,819	18,874	0.00
Enterprise Value (EV)	33,920	38,059	0.00	49,020	34,135	33,669	31,465	0.00
Market Capitalization	22,123	26,516	0.00	40,596	25,040	24,271	24,388	0.00
Book Value per Share	$49.39	$50.68	$47.95	$41.55	$39.04	$37.58	$39.09	$9.88
Tangible Book Value per Share	$21.34	$21.81	$20.71	$15.97	$13.58	$13.89	$17.26	$9.69
Total Capital	37,057	37,640	37,721	33,325	33,514	33,759	33,816	12,744
Total Debt	12,615	12,439	11,858	9,626	11,111	10,890	9,391	4,441
Total Long-Term Debt	10,044	10,112	9,174	7,521	10,938	9,412	7,767	3,711
Net Debt	11,762	11,498	10,957	8,424	9,095	9,398	7,077	4,325
Capital Expenditures (CapEx)	0.00	0.00	0.00	0.00	0.00	1,891	0.00	651
Debt-free, Cash-free Net Working Capital (DFCFNWC)	3,465	3,435	3,845	3,009	1,709	2,343	2,637	2,335
Debt-free Net Working Capital (DFNWC)	4,318	4,376	4,746	3,508	3,163	3,014	4,951	2,451
Net Working Capital (NWC)	1,747	2,049	2,062	1,403	2,990	1,536	3,327	1,721
Net Nonoperating Expense (NNE)	444	521	422	468	625	180	566	-181
Net Nonoperating Obligations (NNO)	-11,540	-11,699	-10,810	8,424	9,095	9,398	7,077	4,325
Total Depreciation and Amortization (D&A)	2,339	2,169	2,012	1,951	1,989	1,799	1,592	0.00
Debt-free, Cash-free Net Working Capital to Revenue	13.34%	11.82%	10.15%	10.86%	8.17%	11.67%	14.05%	51.35%
Debt-free Net Working Capital to Revenue	16.63%	15.06%	12.53%	12.66%	15.13%	15.01%	26.37%	53.90%
Net Working Capital to Revenue	6.73%	7.05%	5.44%	5.06%	14.30%	7.65%	17.72%	37.85%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.36	$2.53	$14.22	$5.53	$0.81	$3.40	$5.72	$0.00
Adjusted Weighted Average Basic Shares Outstanding	494.20M	496.38M	538.48M	569.66M	569.66M	582.27M	624.90M	0.00
Adjusted Diluted Earnings per Share	$1.36	$2.53	$14.18	$5.52	$0.81	$1.70	$5.72	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	494.37M	496.99M	540.01M	571.29M	569.69M	583.10M	624.90M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	0.00	569.26M	572.94M	608.54M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	1,470	2,311	7,524	3,672	1,208	1,321	1,556	146
Normalized NOPAT Margin	5.66%	7.95%	19.86%	13.25%	5.78%	6.58%	8.29%	3.22%
Pre Tax Income Margin	4.37%	6.72%	27.05%	15.04%	1.83%	6.51%	18.61%	-0.64%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	32.87%	224.40%	82.95%	26.64%	100.92%
Augmented Payout Ratio	0.00%	0.00%	0.00%	65.43%	259.26%	239.61%	77.02%	100.92%

No quarterly metrics and ratios for Nutrien are available.

Frequently Asked Questions About Nutrien's Financials

When does Nutrien's financial year end?

According to the most recent income statement we have on file, Nutrien's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Nutrien's net income changed over the last 7 years?

Nutrien's net income appears to be on an upward trend, with a most recent value of $700 million in 2024, rising from $327 million in 2017. The previous period was $1.28 billion in 2023. Check out Nutrien's forecast to explore projected trends and price targets.

What is Nutrien's operating income?

Nutrien's total operating income in 2024 was $1.86 billion, based on the following breakdown:

Total Gross Profit: $7.53 billion
Total Operating Expenses: $5.28 billion

How has Nutrien revenue changed over the last 7 years?

Over the last 7 years, Nutrien's total revenue changed from $4.55 billion in 2017 to $25.97 billion in 2024, a change of 471.2%.

How much debt does Nutrien have?

Nutrien's total liabilities were at $27.40 billion at the end of 2024, a 0.5% decrease from 2023, and a 215.1% increase since 2017.

How much cash does Nutrien have?

In the past 7 years, Nutrien's cash and equivalents has ranged from $116 million in 2017 to $2.31 billion in 2018, and is currently $853 million as of their latest financial filing in 2024.

How has Nutrien's book value per share changed over the last 7 years?

Over the last 7 years, Nutrien's book value per share changed from 9.88 in 2017 to 49.39 in 2024, a change of 399.7%.

Related Companies

This page (NYSE:NTR) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nutrien (NTR) Financials

Frequently Asked Questions About Nutrien's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nutrien (NTR) Financials

Annual Income Statements for Nutrien

Quarterly Income Statements for Nutrien

Annual Cash Flow Statements for Nutrien

Quarterly Cash Flow Statements for Nutrien

Annual Balance Sheets for Nutrien

Quarterly Balance Sheets for Nutrien

Annual Metrics And Ratios for Nutrien

Quarterly Metrics And Ratios for Nutrien

Frequently Asked Questions About Nutrien's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools